Literature DB >> 21771644

Atropine maintenance dosage in patients with severe organophosphate pesticide poisoning.

Horst Thiermann1, Dirk Steinritz, Franz Worek, Maria Radtke, Peter Eyer, Florian Eyer, Norbert Felgenhauer, Thomas Zilker.   

Abstract

Although the importance of atropine in therapy of organophosphate (OP) poisoning is generally recognized, its dosing is a matter of debate. A retrospective analysis of atropine dosing was undertaken in 34 patients who had been enrolled in a clinical study assessing obidoxime effectiveness in OP-poisoning. All patients were severely intoxicated (suicidal attempts) and required artificial ventilation. Atropine was administered routinely by intensive care physicians for life-threatening muscarinic symptoms, with the recommendation to favor low dosage. The pharmacological active enantiomere S-hyoscyamine was determined by a radioreceptor assay. When RBC-AChE activity ranged between 10% and 30%, S-hyoscyamine plasma concentrations of approx. 5 nmol L⁻¹ were sufficient. This concentration could be maintained with about 0.005 mg h⁻¹ kg⁻¹ atropine. Only when RBC-AChE was completely inhibited, therapy of cholinergic crisis required atropine doses up to 0.06 mg h⁻¹ kg⁻¹. Elimination half-life of S-hyoscyamine was 1.5 h, showing occasionally a second slow elimination phase with t(½)=12 h. Malignant arrhythmias were observed in some 10% of our cases, which occurred late and often in the absence of relevant glandular cholinergic signs, when the S-hyoscyamine concentration was below 2.5 nmol L⁻¹. Arrhythmias mostly resolved on reinstitution of atropine.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21771644     DOI: 10.1016/j.toxlet.2011.07.006

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  4 in total

1.  Pharmacology, Pharmacokinetics, and Tissue Disposition of Zwitterionic Hydroxyiminoacetamido Alkylamines as Reactivating Antidotes for Organophosphate Exposure.

Authors:  Rakesh K Sit; Zrinka Kovarik; Nikolina Maček Hrvat; Suzana Žunec; Carol Green; Valery V Fokin; K Barry Sharpless; Zoran Radić; Palmer Taylor
Journal:  J Pharmacol Exp Ther       Date:  2018-09-06       Impact factor: 4.030

2.  Pyridostigmine Suicidal Attempt in a Myasthenia Gravis Patient.

Authors:  Mohammed Aref T Malabaey; Ahad A Al-Saud; Yasser A Alaska; Afnan Almas; Almas Malik
Journal:  Am J Case Rep       Date:  2019-09-26

3.  Severe oral and intravenous insecticide mixture poisoning with diabetic ketoacidosis: a case report.

Authors:  Narjis Badrane; Majda Askour; Kamal Berechid; Khalid Abidi; Tarek Dendane; Amine Ali Zeggwagh
Journal:  BMC Res Notes       Date:  2014-07-31

Review 4.  Counteracting poisoning with chemical warfare nerve agents.

Authors:  Nikolina Maček Hrvat; Zrinka Kovarik
Journal:  Arh Hig Rada Toksikol       Date:  2020-12-31       Impact factor: 2.078

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.